8-K/A

AMENDMENT TO CURRENT REPORT

Company: TENAX THERAPEUTICS, INC.
Filed: January 22, 2014
Period of Report: November 13, 2013
Accession Number: 0001354488-14-000293

View Document ↗ View on SEC.gov ↗